HTI-1 - Moligand™ , CAS No.H610870

CAS: H610870 Cat. No.: H610870 PubChem CID: 154699468
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Synonyms
compound 1c
Storage
Room temperature
★
Size
Germany (EU)
USA*
Price
Qty
5mg
H610870-5mg
Made to order · 8–12 wks
€694.10
25mg
H610870-25mg
Made to order · 8–12 wks
€1,488.09
Enter a quantity for the sizes you want to add.
🧪
Why this grade

Moligand™ Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Room temperature Ships Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Specifications

Synonyms
compound 1c
Specifications & Purity
Moligand™
Storage
Room temperature
Grade
Moligand™
Names and Identifiers
Canonical Smiles
OC[C@H]1OC(O)[C@@H]([C@H]([C@@H]1O)OCCCCCCCCOc1ccc2c(c1)cccn2)O
IUPAC Name
(3R,4S,5R,6R)-6-(hydroxymethyl)-4-(8-quinolin-6-yloxyoctoxy)oxane-2,3,5-triol
InChIKey
PHDIJLFSKNMCMI-ITGJKDDRSA-N
INCHI
1S/C23H33NO7/c25-15-19-20(26)22(21(27)23(28)31-19)30-13-6-4-2-1-3-5-12-29-17-9-10-18-16(14-17)8-7-11-24-18/h7-11,14,19-23,25-28H,1-6,12-13,15H2/t19-,20-,21-,22+,23?/m1/s1
PubChem CID
154699468

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

3D Structure
Interactive Chemical Structure Model





Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested applications or validated protocols are provided for HTI-1 in the Product Data. The following general procedures are commonly used for small-molecule library members in research settings.

General small-molecule stock preparation

  • Equilibrate vial to room temperature before opening. Minimize exposure to ambient humidity.
  • Prepare a 10–50 mM stock in anhydrous DMSO (or another suitable solvent identified by solubility screening). Vortex thoroughly; sonicate briefly if needed. Inspect for clarity.
  • Aliquot into low-bind tubes or plated format to minimize freeze–thaw cycles and headspace. Label with compound ID (HTI-1), lot, concentration, solvent, and date.

Assay dilution (example framework)

  • Add stock to assay buffer to achieve desired final concentration while keeping DMSO ≤0.5–1% v/v (as permitted by your assay). Mix gently and check for precipitation.
  • Include vehicle controls matched to the highest solvent concentration and, where appropriate, detergent controls to probe aggregation.

Analytical verification

  • Verify concentration by UV–Vis if a suitable chromophore exists and extinction coefficient is known; otherwise, quantify by LC–MS against a calibration curve. Confirm stability over the assay timeframe.

Note: These are general recommendations and not item-specific validated methods.

Biological Roles

Item-specific biological function, target class, or pathway engagement for HTI-1 is not provided in the Product Data, and no biological claims are made here.

General considerations for small-molecule library members

  • Such compounds are often used to explore biochemical binding, modulate enzyme activity in vitro, or probe protein–ligand interactions in biophysical assays (e.g., DSF, ITC, SPR). Any observed activity should be treated as preliminary until validated with orthogonal methods and concentration–response analysis.
  • Potential interference: Some chemotypes can act as PAINS (pan-assay interference compounds) or aggregate at micromolar concentrations. Employ counterscreens (with and without detergent), redox/thiol reactivity tests, and orthogonal assay formats.
  • ADME-relevant properties (solubility, permeability, stability) should be determined experimentally if biological testing is pursued; none are specified for this item.

Research-use statement

  • This product is solely for research use in laboratory settings. It is not intended as a drug, diagnostic, or for any clinical application. Any biological roles or mechanisms must be established by the end user using validated protocols and quality-controlled materials.
Buffer Applications

HTI-1 is a small organic compound from a screening library and is not a buffering agent. No buffer capacity or buffer system applicability is provided in the Product Data.

  • Not typically applicable: This item is not used to prepare buffer systems or control pH.
  • Practical note (general): If assaying the compound in aqueous systems, prepare assay buffers (e.g., PBS, HEPES, Tris) independently and add the compound as a DMSO or other solvent stock, keeping the final organic content within your assay’s tolerance (often ≤0.5–1% v/v).
  • Verify precipitation upon dilution by visual inspection or light scattering, and adjust buffer composition (pH, ionic strength, small percentage of co-solvent, or nonionic surfactant) only as permitted by the biological system under study.
Green Alternatives

Because item-specific solubility and stability data for HTI-1 are not provided, solvent selection should balance performance with greener chemistry principles where possible.

Potential greener choices (general guidance)

  • For stock solutions
    • DMSO is common; while not “green,” it is relatively low-toxicity and has good biodegradability. Keep final assay % as low as feasible (≤0.5–1%).
    • Consider propylene carbonate or Cyrene (dihydrolevoglucosenone) for certain workflows; each has higher boiling points and different polarity profiles but may not be compatible with all assays or aqueous dilutions.
  • For work-up and purification (if applicable to analog synthesis)
    • Prefer ethyl acetate, isopropanol, and 2-MeTHF over chlorinated solvents where performance allows.
    • Replace DMF/NMP with GBL, polar alcohols, or green amide alternatives where chemistry permits.

Trade-offs

  • Cyrene and propylene carbonate can show limited water miscibility or elevated viscosity, complicating automated liquid handling.
  • 2-MeTHF and CPME offer greener profiles vs. THF/Et2O but may differ in peroxide formation tendencies and azeotropes; ensure inhibitor/peroxide monitoring where relevant.

Recommendation

  • Start with minimal-volume DMSO stocks for screening and evaluate greener co-solvents in confirmatory assays. Document solvent composition rigorously to ensure reproducibility and enable subsequent optimization.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or manufacturing use is provided for HTI-1 in the Product Data. This item is labeled for research use only.

  • Not for clinical, diagnostic, or therapeutic applications.
  • If used in pre-formulation research (in vitro only), determine key properties (solubility vs pH, stability, hygroscopicity) experimentally. None are specified here for this item.
  • Do not incorporate into any product intended for human or veterinary administration.

Documentation

  • Maintain CoA/SDS and internal records (lot number, preparation notes) for research traceability.
  • For any scale-up or formulation feasibility study in a research setting, establish compatibility with excipients and packaging materials under controlled laboratory conditions; no such data are provided for this product.
Physical Properties

Item-specific physicochemical constants are not provided in the Product Data for HTI-1 (H610870). Use the lot-specific CoA/Spec Sheet for authoritative values.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD, pKa: Not specified for this item; refer to CoA/Spec Sheet.

General characterization guidance (literature/practice)

  • If the solid form is received, determine approximate MP by DSC or capillary method to confirm identity and assess polymorph/solvate presence.
  • Solubility screening for assay stocks typically tests DMSO (100%), water (pH 7.4 buffer), MeOH, EtOH, acetonitrile, and PBS + a small percentage of co-solvent; start at 1–10 mM targets for HTS stocks.
  • If needed, estimate logP and pKa computationally (e.g., using ACD/Labs, ChemAxon) to inform vehicle selection and storage.
  • Assess hygroscopicity and deliquescence by gravimetry under ambient humidity if the CoA is silent on these attributes.
  • Check UV–Vis profile (200–400 nm) in your chosen vehicle to identify potential assay interference or to set HPLC monitoring wavelengths (this is general good practice and not item-specific).
Quality and Grades
  • Grade/Purity (Product Data): Moligand™

What Moligand™ signifies (general Aladdin context)

  • Moligand™ designates small-molecule ligands curated for discovery and screening workflows. Typical expectations include suitability for assay stock preparation (commonly in DMSO) and availability of identity/purity confirmation on the CoA (e.g., LC/HPLC area%, MS/NMR where applicable). Specific purity thresholds, residual solvents, metal content, or UV cutoff are not stated in the Product Data for this item.

Item-specific quality attributes

  • Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet.
  • Residual solvent limits, water content (e.g., KF), inorganic impurities, or assay suitability testing: Not specified for this item; refer to CoA/Spec Sheet.

Practical notes for screening use

  • Verify identity and purity of your lot via the supplied analytical data prior to hit confirmation. If necessary, perform orthogonal checks (e.g., HRMS, 1H NMR) and analytical HPLC to ensure single dominant component at the working wavelength.
  • If your assays are UV-based or fluorescence-based, confirm the compound’s background absorbance/fluorescence in the chosen buffer to avoid artifacts.
  • Record the batch/lot number in ELN/LIMS to ensure traceability across screening, counterscreens, and SAR follow-up.
Reaction and Applications

From the Product Data, HTI-1 is offered as part of a small-molecule/compound library under the Moligand™ designation. No specific synthetic or reactive functionality is provided.

  • Primary use (general for Moligand™ items): preparation of research stocks for biochemical, biophysical, or cell-free assay screening; hit validation and structure–activity relationship (SAR) exploration in discovery research settings.
  • Typical workflows
    • Solubilize to 10–50 mM in dry DMSO; verify clarity and lack of precipitate.
    • Perform orthogonal readouts (e.g., fluorescence polarization vs. thermal shift) to mitigate assay artifacts such as aggregation or redox cycling (where applicable).
    • Run counterscreens to detect nonspecific interference (e.g., detergent-sensitive inhibition, promiscuous reactivity with thiols if functional groups warrant—confirm by CoA/structure review).
  • Not typically used as a reagent or catalyst: without structural data, no specific named reactions can be recommended for synthetic chemistry. If the structure is later confirmed to contain useful handles (e.g., aryl halides, amines, acids), standard cross-coupling, amide formation, or alkylation chemistries may be explored for analog generation (general comment, not item-specific).

Important: Avoid biological/therapeutic interpretations; this material is for research use only and any target engagement must be verified independently with authenticated standards and appropriate controls.

Reaction Conditions

No reaction conditions are specified for HTI-1 and, as a Moligand™ library member, it is not primarily intended as a reagent or catalyst.

  • Not applicable for named synthetic transformations without structural details.

General laboratory handling for solution preparation (not a chemical reaction; provided for assay readiness)

  • Prepare concentrated stocks (e.g., 10–50 mM) in an appropriate solvent such as dry DMSO. Vortex, then sonicate briefly if needed to aid dissolution.
  • Filter solutions (0.22–0.45 μm PTFE) if particulate persists and filtration is compatible with the solvent system.
  • Determine stability over time by periodic HPLC/LC–MS checks at intended storage temperatures.

If the compound is later used in derivatization or conjugation chemistry, develop conditions case-by-case following confirmation of functional groups and reactivity from an authenticated structural source and your CoA.

Safety and Handling

Safety details specific to HTI-1 are not provided in the Product Data. Always consult the SDS for your lot before use.

  • GHS classification, signal word, pictograms, and H-statements: Not specified for this item; refer to SDS.
  • Storage condition (Product Data): Room temperature. Maintain container tightly closed in a dry, well-ventilated area.

General laboratory precautions (for small organic research chemicals)

  • PPE: lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Avoid inhalation of dust/aerosols and contact with skin/eyes.
  • Engineering controls: handle powders in a fume hood or ventilated enclosure; minimize exposure by using closed containers and aliquoting tools.
  • Incompatibilities: until specific data are known, segregate from strong oxidizers, strong acids/bases, and ignition sources. Avoid moisture if the compound is hygroscopic (verify on CoA).
  • First aid (overview; defer to SDS): rinse eyes/skin with water for at least 15 minutes upon contact; move to fresh air if inhaled; seek medical attention if irritation persists; if ingested, rinse mouth and obtain medical advice.
  • Spill response: collect solids gently (avoid dust); for solutions, absorb with inert material. Dispose as organic laboratory chemical waste per institutional and local regulations.
  • Environmental precautions: prevent release to drains where feasible. Label and store waste containers properly.

Note: This material is designated “For research use only.” Not for human or veterinary use.

Solvent Selection

Item-specific solubility data are not provided for HTI-1. The following is general guidance for small-molecule library compounds.

  • Primary stock solvent: DMSO is commonly used to prepare 10–50 mM screening stocks due to broad solubilizing power and assay compatibility at ≤0.5–1% final v/v.
  • Secondary vehicles: If DMSO is unsuitable, assess acetonitrile, methanol, or ethanol for intermediate concentrates, with final dilution into aqueous buffers (e.g., PBS, assay buffer) containing ≤1–2% organic cosolvent.
  • Aqueous compatibility: Evaluate kinetic vs equilibrium solubility in your target buffer (pH and ionic strength dependent). Consider 0.01–0.1% nonionic surfactant (e.g., Tween-20) if aggregation is suspected (control experiments recommended).
  • Polarity considerations: Absent structure data, screen a small solvent panel spanning polarity—DMSO (highly polar, aprotic), DMF, acetonitrile, methanol/ethanol (polar protic), ethyl acetate (moderately polar), and isopropanol—as part of a rapid solubility map.

Quick comparison (general)

  • DMSO: maximal solubility, low volatility; may interfere with some enzymes at >1%.
  • Acetonitrile: miscible with water, volatile; limited solubility for very lipophilic compounds.
  • Methanol/Ethanol: good miscibility; watch for enzyme inhibition or spectral overlap in UV assays.

Always confirm solvent choices against your assay’s tolerance and the compound’s stability profile (light, oxygen, hydrolysis) as reported on the CoA/SDS.

Storage and Reconstitution
  • Storage conditions (Product Data): Room temperature. Keep container tightly closed, in a dry place, protected from excessive heat and direct light. Shipped-in conditions not specified.

Reconstitution (general guidance for small molecules)

  • Solid: Allow to equilibrate to room temperature before opening to avoid moisture condensation. If hygroscopicity is unknown, handle quickly and reseal promptly. Use desiccant storage if ambient humidity is high.
  • Solutions: Prepare concentrated stocks (e.g., 10–50 mM) in an appropriate solvent such as anhydrous DMSO. Filter if necessary through PTFE (0.22–0.45 μm). Record solvent, concentration, and preparation date.

Storage of solutions (general best practice)

  • Unless otherwise specified on the CoA/SDS, store DMSO stocks in tightly sealed, inert containers, protected from light. Refrigerated or frozen storage (e.g., 2–8°C or −20°C) can extend shelf life; however, ensure compatibility with the Product Data and your lab’s validation. For this item, solid storage at room temperature is specified; solution storage conditions are user-defined and should be stability-verified.
  • Avoid repeated freeze–thaw; dispense single-use aliquots.

Stability

  • Item-specific stability, sensitivity to air/light/moisture, and re-test period: Not specified for this item; refer to CoA/Spec Sheet. Establish in-house stability by periodic HPLC/LC–MS checks if long-term storage is planned.

Research use only.

Structure and Identity

Concise identity summary for a small-molecule screening ligand listed under Aladdin Moligand.

  • Item name: HTI-1 (SKU: H610870)
  • Category: Small molecules and compound libraries (小分子和化合物库)
  • CAS: H610870 (as provided in Product Data)
  • PubChem CID: 154699468 (Product Data)
  • InChIKey: 277253 (Product Data)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Item-specific structural description (ring systems, heteroatoms, stereochemistry) is not specified in the Product Data and should be confirmed from the CoA or an authenticated structure source linked to the stated CID.

Notes on identity verification (general guidance)

  • Cross-check the printed label (SKU H610870), batch/lot number, and the supplied CoA/SDS prior to use in screening campaigns.
  • For cheminformatics workflows, retrieve the authoritative structure (e.g., canonical SMILES, InChI) from a validated source that matches your lot number. Verify consistency between name “HTI-1,” the stated CID, and any analytical data provided (NMR, HRMS, HPLC).
Synthetic Utility

Based on the Product Data, HTI-1 is supplied as a Moligand™ library compound rather than as a general synthetic reagent or building block. No functional-group information is provided, so specific transformations cannot be recommended.

  • Not typically applicable: Without confirmed structure, discussing named reactions, protecting-group strategies, or cross-coupling handles would be speculative.

General notes if analog work is pursued (after structure confirmation via CoA/validated source)

  • If the scaffold contains common vectors (e.g., anilines, aryl halides, carboxylic acids, nitriles), standard medicinal chemistry disconnections can be explored: amide couplings (HATU/EDC), Suzuki–Miyaura or Buchwald–Hartwig couplings, reductive aminations, and SNAr where appropriate.
  • Prioritize scalability, step economy, and robustness; consider green(er) solvent systems and modern coupling technologies (microwave, flow) where beneficial.

Until full structure/functional-group data are verified for your lot, treat this compound as a screening ligand for biological assays rather than a synthetic intermediate.

Target Specificity

Target, binding site, or selectivity data for HTI-1 are not provided in the Product Data.

  • No antigen/epitope information (not an antibody product).
  • No enzyme/receptor specificity or selectivity panel results are supplied.

Guidance for researchers (general)

  • If using in a target-based assay, confirm activity with concentration–response curves, assess selectivity with orthogonal assays and representative counterscreens, and rule out artifactual readouts (fluorescence quenching, aggregation, redox cycling) before drawing conclusions.
  • Document experimental conditions and solvent percentages to ensure reproducibility across assays and laboratories.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.